Unknown

Dataset Information

0

Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein.


ABSTRACT: The ABC transporter, P-glycoprotein, is an integral membrane protein that mediates the ATP-driven efflux of drugs from multidrug-resistant cancer and HIV-infected cells. Anti-P-glycoprotein antibody C219 binds to both of the ATP-binding regions of P-glycoprotein and has been shown to inhibit its ATPase activity and drug binding capacity. C219 has been widely used in a clinical setting as a tumor marker, but recent observations of cross-reactivity with other proteins, including the c-erbB2 protein in breast cancer cells, impose potential limitations in detecting P-glycoprotein. We have determined the crystal structure at a resolution of 2.4 A of the variable fragment of C219 in complex with an epitope peptide derived from the nucleotide binding domain of P-glycoprotein. The 14-residue peptide adopts an amphipathic alpha-helical conformation, a secondary structure not previously observed in structures of antibody-peptide complexes. Together with available biochemical data, the crystal structure of the C219-peptide complex indicates the molecular basis of the cross-reactivity of C219 with non-multidrug resistance-associated proteins. Alignment of the C219 epitope with the recent crystal structure of the ATP-binding subunit of histidine permease suggests a structural basis for the inhibition of the ATP and drug binding capacity of P-glycoprotein by C219. The results provide a rationale for the development of C219 mutants with improved specificity and affinity that could be useful in antibody-based P-glycoprotein detection and therapy in multidrug resistant cancers.

SUBMITTER: van Den Elsen JM 

PROVIDER: S-EPMC24124 | biostudies-literature | 1999 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein.

van Den Elsen J M JM   Kuntz D A DA   Hoedemaeker F J FJ   Rose D R DR  

Proceedings of the National Academy of Sciences of the United States of America 19991101 24


The ABC transporter, P-glycoprotein, is an integral membrane protein that mediates the ATP-driven efflux of drugs from multidrug-resistant cancer and HIV-infected cells. Anti-P-glycoprotein antibody C219 binds to both of the ATP-binding regions of P-glycoprotein and has been shown to inhibit its ATPase activity and drug binding capacity. C219 has been widely used in a clinical setting as a tumor marker, but recent observations of cross-reactivity with other proteins, including the c-erbB2 protei  ...[more]

Similar Datasets

| S-EPMC3317930 | biostudies-literature
| S-EPMC4498696 | biostudies-literature
| S-EPMC6104738 | biostudies-literature
| S-EPMC5654857 | biostudies-literature
| S-EPMC3314129 | biostudies-literature
2022-06-07 | GSE196820 | GEO
| S-EPMC5594662 | biostudies-literature
| S-EPMC6999842 | biostudies-literature
| S-EPMC3464233 | biostudies-literature
| S-EPMC3346070 | biostudies-literature